Compare Stocks: IONS vs. SMMT vs. AXSM vs. ABVX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IONSSMMTAXSMABVX
Market Snapshot
Current market context for the selected companies.
IONS
$63.36
Market Cap
$10.56B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
SMMT
$14.22
Market Cap
$10.66B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
AXSM
$207.21
Market Cap
$10.76B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ABVX
$116.49
Market Cap
10.29B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | IONS | SMMT | AXSM | ABVX |
|---|---|---|---|---|
| 1 Month | +14.6% | +13.3% | -11.5% | -6.2% |
| 1 Month vs SPY | +11.2% | +10.0% | -14.9% | -9.6% |
| 3 Months | -17.2% | -18.1% | -11.6% | -10.2% |
| 3 Months vs SPY | -19.2% | -20.1% | -13.7% | -12.2% |
| 6 Months | -21.7% | -9.3% | +26.2% | -5.5% |
| 6 Months vs SPY | -32.2% | -19.8% | +15.7% | -16.0% |
| 1 Year | +51.5% | -45.9% | +78.1% | +50.4% |
| 1 Year vs SPY | +32.4% | -65.0% | +59.0% | +31.2% |
| 2 Years | +31.5% | +6.6% | +135.7% | +908.6% |
| 2 Years vs SPY | -5.0% | -30.0% | +99.2% | +872.0% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.